Open | - |
Close | - |
Volume / Avg. | 0 / 221.521K |
Day Range | - - - |
52 Wk Range | 3.350 - 14.000 |
Market Cap | $271.495M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | % |
Days to Cover | 33.01 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Stoke Therapeutics (NASDAQ: STOK) through any online brokerage.
Other companies in Stoke Therapeutics’s space includes: bluebird bio (NASDAQ:BLUE), Inovio Pharmaceuticals (NASDAQ:INO), Gritstone Bio (NASDAQ:GRTS), Mesoblast (NASDAQ:MESO) and Opthea (NASDAQ:OPT).
The latest price target for Stoke Therapeutics (NASDAQ: STOK) was reported by Needham on Friday, February 16, 2024. The analyst firm set a price target for 14.00 expecting STOK to rise to within 12 months (a possible 130.26% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Stoke Therapeutics (NASDAQ: STOK) is $6.08 last updated March 18, 2024 at 4:01 PM EDT.
There are no upcoming dividends for Stoke Therapeutics.
Stoke Therapeutics’s Q1 earnings are confirmed for Thursday, May 2, 2024.
There is no upcoming split for Stoke Therapeutics.
Stoke Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.